Overall, our findings indicate that tau pathology engages distinct lipid, peptide-catabolic and bioenergetic programs according to ethnoracial background, underscoring the need for population-aware mechanistic models and therapeutic strategies in Alzheimer’s disease. This evidence concerns the gene MAPT and Alzheimer disease.